Lu Yue Y - OmicsDI

Show results for

Unknown (570)
Proteomics (54)
Genomics (18)
Metabolomics (10)
Transcriptomics (8)

Organisms

Homo sapiens (42)
Acidithiobacillus ferrooxidans ATCC 53993 (15)
Aerococcus urinae NBRC 15544 = CCUG 36881 (15)
Allexis (15)
Arabidopsis thaliana (15)
Cyanophora paradoxa (15)
Ensifer adhaerens (15)
Enterococcus faecalis (15)
Globicatella sanguinis (15)
Helianthus annuus (15)
Histomonas meleagridis (15)
Leishmania major strain Friedlin (15)
Listeria monocytogenes (15)
Lotus japonicus (15)
Marchantia polymorpha (15)
Medicago truncatula (15)
Methylohalobius crimeensis 10Ki (15)
Mus musculus (7)
Ovis aries (2)
Escherichia coli (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Brassica oleracea (1)
Bubalus bubalis (1)
Clostridium ljungdahlii DSM 13528 (1)
Drosophila melanogaster (1)
Macaca fascicularis fascicularis (1)
Macaca mulatta (1)
Oryza sativa (1)
Spinacia oleracea (1)
Triticum aestivum (1)

Repository

iProX (36)
biostudies-arrayexpress (19)
pride (15)
MetaboLights (10)
EGA (7)
MassIVE (3)

Tissue

Cell culture (3)
Embryonic stem cell (2)
Testis (2)
Blood plasma (1)
Blood serum (1)
Bone marrow (1)
Cerebrospinal fluid (1)
Epithelial cell (1)
Hepatocyte (1)
Liver (1)
Thyroid nodule (1)
Whole body (1)

Disease

Hepatocellular carcinoma (1)
Long COVID (1)

Technology Type

Mass Spectrometry (15)
Mass spectrometry (9)
Shotgun proteomics (7)
Bottom-up proteomics (2)
Data-dependent acquisition (2)
SWATH MS (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
HDMSE (1)
Olink affinity proteomics (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
Liquid Chromatography MS - negative - reverse phase (4)
6540 Q-TOF LC/MS (Agilent) (3)
Illumina HiSeq 2500 (1)
Orbitrap Fusion ETD (1)
Q Exactive (1)
Q Exactive Plus (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)

Publication Date

2025 (10)
2024 (10)
2023 (10)
2022 (9)
2014 (7)
2013 (7)
2020 (7)
2026 (6)
2021 (6)
2016 (4)
2011 (2)
2017 (2)
2012 (1)
2019 (1)
2018 (1)

CHEBI ID

CHEBI:16750 (4)
CHEBI:17154 (4)
CHEBI:134647 (3)
CHEBI:67055 (3)
CHEBI:183259 (3)
CHEBI:91312 (3)
CHEBI:74349 (3)
CHEBI:19475 (3)
CHEBI:183650 (3)
CHEBI:136218 (3)
CHEBI:67058 (3)
CHEBI:84818 (3)
CHEBI:16852 (3)
CHEBI:9299 (3)
CHEBI:17521 (3)
CHEBI:42255 (3)
CHEBI:64575 (3)
CHEBI:64549 (3)
CHEBI:64566 (3)
CHEBI:64561 (3)
CHEBI:67057 (3)
CHEBI:17822 (3)
CHEBI:16870 (3)
CHEBI:53487 (3)
CHEBI:68433 (3)
CHEBI:1879 (3)
CHEBI:17620 (3)
CHEBI:27266 (3)
CHEBI:32805 (3)
CHEBI:25094 (3)

Metabolite Name

PC (16:0/17:1) (2)
13,14-Dihydro prostaglandin E1 (2)
3'-O-Methylcytidine (2)
D-3-Phenyllactic acid (2)
Dopaquinone (2)
Cis-7-Hexadecenoic Acid (2)
N-Acetyl-aspartic acid (2)
Quercetin-3beta-D-glucoside (2)
3-Nitro-L-Tyrosine (2)
Benzyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside (2)
Noradrenaline (2)
Chrysin (2)
O-Acetyl-L-carnitine (2)
Valine (2)
4-Pyridoxic acid (2)
N-Acetylglycine (2)
19-Nortestosterone (2)
LPE 18:2 (2)
23-Nordeoxycholic acid (2)
Alpha-Ketoglutaric acid (2)
Gamma-Glu-Leu (2)
PC (17:0/18:2) (2)
Methylmalonate (2)
D-Fructose 6-phosphate (2)
Glu-Gln (2)
LPE 22:5 (2)
2-Amino-1,3-octadecanediol (2)
Nicotinamide (2)
Asp-Phe methyl ester (2)
LPE 20:3 (2)

Study type

Methylation profiling by high throughput sequencing (7)
RNA-seq of coding RNA (5)
ChIP-seq (4)
Other (2)
Transcription profiling by array (1)

Release Date

2024 (85)
2025 (83)
2022 (80)
2023 (69)
2020 (56)
2021 (55)
2019 (29)
2016 (20)
2017 (19)
2018 (18)
2014 (16)
2013 (15)
2026 (15)
2015 (15)
2012 (6)
2011 (4)
2009 (2)
2007 (1)
2005 (1)

Lab affiliation

Nankai University (2)
State Key Laboratory of Reproductive Medicine and Offspring Health， Nanjing Medical University, Nanjing, China. (2)
1 Department of General Surgery, The 306th Hospital of PLA-Peking University Teaching Hospital, Beijing 100101, China 2 Department of General Surgery, Strategic Support Force Medical Center, Beijing 100101, China (1)
Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformation (1)
College of Pharmceutial Science, Zhejiang University of Technology (1)
Department of Hernia and Abdominal Wall Surgery, General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China. (1)
ETH Zurich (1)
Northwest University (1)
Pharmaceutical science, Zhejiang University of Technology (1)
Princess Margaret Cancer Centre, University Health Network, M5G 1L7, Toronto, Canada (1)
Stanford University, California, United States (1)
The Center for Chemical Biology, Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (1)
The Second Affiliated Hospital of Zhejiang University, Medicine Cancer Institute (1)

Previous page
1 / 66
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 66
Next page

Sort by:

Relevance

Page size

Tracing Bai-Yue Ancestry in Aboriginal Li People on Hainan Island.

Not available

S-EPMC9585476 | biostudies-literature

Decreased temporal variabilities of functional connectivities in insula and lingual gyrus are associated with better early treatment response in patients with panic disorder.

Not available

S-EPMC11573430 | biostudies-literature

High incidence of gallstones after Roux-en-Y reconstruction gastrectomy in gastric cancer: a multicenter, long-term cohort study.

Not available

S-EPMC11020035 | biostudies-literature

Genetic evidence of tri-genealogy hypothesis on the origin of ethnic minorities in Yunnan.

Not available

S-EPMC9306206 | biostudies-literature

Pan-cancer analysis of DTX3L as a potential prognostic and immunological biomarker.

Not available

S-EPMC12820253 | biostudies-literature

TMT proteomic analysis of thyroid cancer tissue sample

Our study aimed to adopt a proteomics strategy for analysing changes in the levels of proteins between PTC and para-tumour specimens. A integrative strategy was adopted to identify the important pathways in PTC.

ORGANISM(S): Homo sapiens (Human)

2021-12-14 | PXD027538 | Pride

m6A-dependent regulation of messenger RNA stability

N6-methyladenosine (m6A) is the most prevalent internal modification present in the mRNA of all higher eukaryotes. Here we present that m6A is selectively recognized by human YTH domain family (YTHDF2) protein to regulate mRNA degradation. By using crosslinking and immunoprecipitation, we have ident...

ORGANISM(S): Homo sapiens

2013-11-29 | E-GEOD-49339 | biostudies-arrayexpress

Architecture of Epigenetic Reprogramming Following Twist1 Mediated Epithelial-Mesenchymal Transition [DREAM-seq]

Purpose: to characterize epigenetic changes following Twist1 mediated Epithelial-Mesenchymal Transition in human Methods: we characterized the epigenetic and transcriptome landscapes using whole genome transcriptome analysis by RNA-seq, DNA methylation by digital restriction enzyme analysis of meth...

ORGANISM(S): Homo sapiens

2013-12-10 | E-GEOD-53025 | biostudies-arrayexpress

Architecture of Epigenetic Reprogramming Following Twist1 Mediated Epithelial-Mesenchymal Transition [ChIP-seq]

ORGANISM(S): Homo sapiens

2013-12-10 | E-GEOD-53023 | biostudies-arrayexpress

Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma.

Not available

S-EPMC9273781 | biostudies-literature

Previous page
1 / 66
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 66
Next page

Sort by:

Relevance

Page size

660 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets